KCNQ3 and Encephalopathy: Not surprisingly, patients with encephalopathy resulting from GoF KCNQ3 variations do not benefit from treatment with sodium channel blockers, while retigabine can even aggravate encephalopathy symptoms [40,41,42,43,44,45].